[March 24, 2008] Neurogen Auditors Add Going Concern Qualification To 10K Tweet (InvesTrend Via Thomson Dialog NewsEdge) March 24, 2008 (FinancialWire) Neurogen Corp.'s (NASDAQ: NRGN) auditors added a "going concern" qualification to their opinion in the company's 2007 financial statements included in Neurogen's annual report on Form 10-K. Auditors add a going concern qualification when they are concerned that the company, based on its financials, lacks the ability to continue to meet its obligations for the following year. Branford, Connecticut-based Neurogen is a drug discovery and development company with clinical programs in insomnia, Parkinson's disease, restless legs syndrome, pain, anxiety, and schizophrenia. The company focuses its small molecule drug discovery efforts on specialist care indications with unmet medical need. FinancialWire is a fully independent, proprietary news wire service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation from any company for its news or opinions. All FinancialWire news is available at http://www.financialwire.net . The FinancialWire NewsFeed is available in multiple formats at http://www.investrend.com/XmlFeeds?level=268 . Please address any inquiries to [email protected] . Free annual reports for companies mentioned in the news are available at http://investrend.ar.wilink.com/?level=279 . (Distributed for Investrend Communications, Inc. via M2 Communications Ltd (www.m2.com)) Copyright ? 2008 M2 Communications Ltd. [ Back To TMCnet.com's Homepage ]